CatalystAlert

Search CatalystAlert

Search for companies, drugs, and catalysts

Search CatalystAlert

Search for companies, drugs, and catalysts

BioSpace
Original article

Webinar: Streamlining Nonclinical Development with FDA NAMs

RegulatoryPositive
AI Analysis

Summary

FDA's draft guidance on non-animal methods (NAMs) is being discussed in a webinar to help sponsors streamline nonclinical development and support IND decision-making. This is an informational webinar announcement on regulatory best practices.

Importance:2/10
Sentiment:
0.30
FDA guidancenon-animal methodsnonclinical developmentINDregulatorywebinar

Read the original article

Published by BioSpace on July 1, 2026 6:54 PM

Read Original